| Insight and medication adherence in schizophrenia: An analysis of the CATIE trial J Kim, M Ozzoude, S Nakajima, P Shah, F Caravaggio, Y Iwata, ... Neuropharmacology 168, 107634, 2020 | 92 | 2020 |
| Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase … B Davidson, C Hamani, JS Rabin, M Goubran, Y Meng, Y Huang, ... Molecular psychiatry 25 (9), 1946-1957, 2020 | 64 | 2020 |
| Hippocampal segmentation for brains with extensive atrophy using three‐dimensional convolutional neural networks M Goubran, EE Ntiri, H Akhavein, M Holmes, S Nestor, J Ramirez, ... Human brain mapping 41 (2), 291-308, 2020 | 62 | 2020 |
| Ontario neurodegenerative disease research initiative (ONDRI): structural MRI methods and outcome measures J Ramirez, MF Holmes, CJM Scott, M Ozzoude, S Adamo, GM Szilagyi, ... Frontiers in neurology 11, 847, 2020 | 33 | 2020 |
| Comparison of quality control methods for automated diffusion tensor imaging analysis pipelines SMH Haddad, CJM Scott, M Ozzoude, MF Holmes, SR Arnott, ... PloS one 14 (12), e0226715, 2019 | 26 | 2019 |
| Deep Bayesian networks for uncertainty estimation and adversarial resistance of white matter hyperintensity segmentation P Mojiri Forooshani, M Biparva, EE Ntiri, J Ramirez, L Boone, MF Holmes, ... Human Brain Mapping 43 (7), 2089-2108, 2022 | 25 | 2022 |
| Association between catastrophizing and dizziness-related disability assessed with the dizziness catastrophizing scale DD Pothier, P Shah, L Quilty, M Ozzoude, WA Dillon, JA Rutka, ... JAMA Otolaryngology–Head & Neck Surgery 144 (10), 906-912, 2018 | 22 | 2018 |
| Improved segmentation of the intracranial and ventricular volumes in populations with cerebrovascular lesions and atrophy using 3D CNNs EE Ntiri, MF Holmes, PM Forooshani, J Ramirez, F Gao, M Ozzoude, ... Neuroinformatics, 1-22, 2021 | 20 | 2021 |
| Cortical thickness estimation in individuals with cerebral small vessel disease, focal atrophy, and chronic stroke lesions M Ozzoude, J Ramirez, PR Raamana, MF Holmes, K Walker, CJM Scott, ... Frontiers in Neuroscience 14, 598868, 2020 | 20 | 2020 |
| Characteristics of the Ontario neurodegenerative disease research initiative cohort KM Sunderland, D Beaton, SR Arnott, P Kleinstiver, D Kwan, ... Alzheimer's & Dementia 19 (1), 226-243, 2023 | 19 | 2023 |
| Parkinson's Disease, NOTCH3 Genetic Variants, and White Matter Hyperintensities J Ramirez, AA Dilliott, MA Binns, DP Breen, EC Evans, D Beaton, ... Movement Disorders 35 (11), 2090-2095, 2020 | 19 | 2020 |
| Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET J Ottoy, M Ozzoude, K Zukotynski, S Adamo, C Scott, V Gaudet, J Ramirez, ... Alzheimer's & Dementia 19 (4), 1503-1517, 2023 | 18 | 2023 |
| Blood–brain barrier opening of the default mode network in Alzheimer’s disease with magnetic resonance-guided focused ultrasound Y Meng, M Goubran, JS Rabin, M McSweeney, J Ottoy, CB Pople, ... Brain 146 (3), 865-872, 2023 | 18 | 2023 |
| Neurofilament‐light in former athletes: a potential biomarker of neurodegeneration and progression F Taghdiri, N Multani, M Ozzoude, A Tarazi, M Khodadadi, R Wennberg, ... European Journal of Neurology 27 (7), 1170-1177, 2020 | 18 | 2020 |
| Small and large magnetic resonance imaging–visible perivascular spaces in the basal ganglia of parkinson's disease patients J Ramirez, SA Berberian, DP Breen, F Gao, M Ozzoude, S Adamo, ... Movement Disorders 37 (6), 1304-1309, 2022 | 17 | 2022 |
| Cognitive and neuroimaging profiles of older adults with attention deficit/hyperactivity disorder presenting to a memory clinic BL Callahan, N Ramakrishnan, P Shammi, D Bierstone, R Taylor, ... Journal of Attention Disorders 26 (8), 1118-1129, 2022 | 17 | 2022 |
| MRI-visible perivascular space volumes, sleep duration and daytime dysfunction in adults with cerebrovascular disease J Ramirez, MF Holmes, C Berezuk, D Kwan, B Tan, D Beaton, CJM Scott, ... Sleep Medicine 83, 83-88, 2021 | 14 | 2021 |
| An overview of the quality assurance and quality control of magnetic resonance imaging data for the Ontario Neurodegenerative Disease Research Initiative (ONDRI): pipeline … CJM Scott, SR Arnott, A Chemparathy, F Dong, I Solovey, T Gee, ... BioRxiv, 2020.01. 10.896415, 2020 | 14 | 2020 |
| Insight into illness and its relationship to illness severity, cognition and estimated antipsychotic dopamine receptor occupancy in schizophrenia: an antipsychotic dose … P Gerretsen, H Takeuchi, M Ozzoude, A Graff-Guerrero, H Uchida Psychiatry Research 251, 20-25, 2017 | 12 | 2017 |
| The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical … M Ozzoude, S Nakajima, E Plitman, JK Chung, J Kim, Y Iwata, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 89, 207-213, 2019 | 10 | 2019 |
